BIBLIOGRAFIA SUI DANNI DA VACCINI - MEDNAT.org

Lieu TA, Ray GT, Black SB, Butler JC, Klein JO, Breiman RF et al. Projected cost­effectiveness of pneumococcal conjugate vaccination of healthy infants
and young children. JAMA 2000; 283(11):1460­1468.
Lieu, T. A., Black, S. B., Ray, G. T., Martin, K. E., Shinefield, H. R., and Weniger, B. G. The hidden costs of infant vaccination. Vaccine 2000 Aug
15;19(1):33­41
Lifson, A. R., Roddy, M., and Ehresmann, K. R. The association of poverty and low immunization rates in ZIP code areas. A retrospective survey of
Minnesota kindergartners. Minn Med 2000 Aug;83(8):51­5
Limcangco MR, Salole EG, Armour CL. Epidemiology of Haemophilus influenzae type b meningitis in Manila, Philippines, 1994 to 1996.
Pediatr.Infect.Dis.J. 2000;7­11.
Lina, B., Fletcher, M. A., Valette, M., Saliou, P., and Aymard, M. A TritonX­100­split virion influenza vaccine is safe and fulfills the committee for
proprietary medicinal products (CPMP) recommendations for the European Community for Immunogenicity, in Children, Adults and the Elderly.
Biologicals 2000 Jun;28(2):95­103
Lindenburg K, Langendam MW, Veenstra J, Miedema F, Coutinho R. Long­term effects of therapeutic vaccination with rgp 120 [letter]. AIDS 2000;
14(2):203­204.
Linnemann T, Wiesmuller KH, Gellrich S, Kaltoft K, Sterry W, Walden P. A T­cell epitope determined with random peptide libraries and combinatorial
peptide chemistry stimulates T cells specific for cutaneous T­cell lymphoma. Ann Oncol 2000; 11 Suppl 1:95­99.
Liozon E, Ittig R, Vogt N, Michel JP, Gold G. Polymyalgia rheumatica following influenza vaccination. J Am Geriatr Soc. 2000 Nov;48(11):1533­4.
Liu MA, Ulmer JB. Gene­based vaccines. Mol Ther 2000 Jun;1(6):497­500.
Ljungberg K, Wahren B, Almqvist J, Hinkula J, Linde A, Winberg G. Effective construction of DNA vaccines against variable influenza genes by homologous
recombination. Virology 2000; 268(2):244­250.
Loche F, Schwarze HP, Thedenat B, Carriere M, Bazex J. Erythema multiforme associated with hepatitis B immunization. Clin Exp Dermatol. 2000
Mar;25(2):167­8.
Lodha R, Dash NR, Kapil A, Kabra SK. Diphtheria in urban slums in north India [letter]. Lancet 2000;204.
Lok AS. Hepatitis B infection: pathogenesis and management. J Hepatol 2000; 32(1 Suppl):89­97.
Lonergan, G. and Rivest, P. What is a safe vaccine? [letter]. Vaccine 2000 Aug 15;19(1):1
Lutwick LI, Abramson JM. Pediatric immunization for the future. Lyme disease vaccine and beyond. Pediatr Clin North Am 2000; 47(2):465­79, viii.
Lutwick LI, Rubin LG. Childhood immunizations 2000. Introduction. Pediatr Clin North Am 2000; 47(2):xi­xiv.
Lutwick SM. Pediatric vaccine compliance. Pediatr Clin North Am 2000; 47(2):427­434.
MacDonald NE, Halperin SA, Law BJ, Danzig LE, Granoff DM. Can meningococcal C conjugate vaccine overcome immune hyporesponsiveness induced by
previous administration of plain polysaccharide vaccine? [letter]. JAMA 2000; 283(14):1826­1827.
Macedo G, Maia JC, Gomes A, Teixeira A, Ribeiro T. Efficacy of a reinforced protocol of HBV vaccination in cirrhotic patients waiting for orthotopic liver
transplantation. Transplant Proc 2000 Dec;32(8):2641
Maddrey WC. Hepatitis B: an important public health issue. J Med Virol 2000 Jul;61(3):362­6.
Magdei M, Melnic A, Benes O, Bukova V, Chicu V, Sohotski V et al. Epidemiology and control of diphtheria in the Republic of Moldova, 1946­1996. J Infect
Dis 2000; 181 Suppl 1:S47­S54.
Maillefert JF, Tavernier C, Sibilia J, Vignon E. Exacerbation of systemic lupus erythematosus after hepatitis B vaccination: comment on the article by
Battafarano et al and the letter by Senecal et al [letter]. Arthritis Rheum. 2000;468­9.
Makela PH. Vaccines, coming of age after 200 years. FEMS Microbiol.Rev. 2000;9­20.
Malay S, Tizer K, Lutwick LI. Current update of pediatric hepatitis vaccine use. Pediatr Clin North Am 2000; 47(2):395­406, vii.
Malhotra A, Krilov LR. Influenza and respiratory syncytial virus. Update on infection, management, and prevention. Pediatr Clin North Am 2000; 47(2):353­
vii.
Mallet E, Fabre P, Pines E, Salomon H, Staub T, Schodel F, Mendelman P, Hessel L, Chryssomalis G, Vidor E, et al. Immunogenicity and safety of a new
liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants. Hexavalent Vaccine Trial Study Group.
Pediatr Infect Dis J 2000 Dec;19(12):1119­27
Malmstrom P. Improved patient outcomes with BCG immunotherapy vs. chemotherapy ­ Swedish and worldwide experience. Eur Urol 2000; 37 Suppl 1:16­
20.
Manzano E, Grau A, Sequeira E, Valles JA. Possible toxicoderma secondary to influenza vaccination. Aten Primaria. 2000 Oct 15;26(6):429.
Maple, P. A., Jones, C. S., Wall, E. C., Vyseb, A., Edmunds, W. J., Andrews, N. J., and Miller, E. Immunity to diphtheria and tetanus in England and Wales.
Vaccine 2000 Sep 15;19(2­3):167­73
Margolis HS, Handsfield HH, Jacobs RJ, Gangi JE. Evaluation of office­based intervention to improve prevention counseling for patients at risk for sexually
acquired hepatitis B virus infection. Hepatitis B­WARE Study Group. Am.J.Obstet.Gynecol. 2000;1­6.
Markina SS, Maksimova NM, Vitek CR, Bogatyreva EY, Monisov AA. Diphtheria in the Russian Federation in the 1990s. J Infect Dis 2000; 181 Suppl
1:S27­S34.
Markoff L. Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines. Vaccine 2000 May 26;18 Suppl
2:26­32.
Marques AR, Straus SE. Herpes simplex type 2 infections­­an update. Adv.Intern.Med. 2000;175­208.
Marshall E. Bioterrorism. DOD retreats on plan for anthrax vaccine [news]. Science 2000 Jul 21;289(5478):382­3.
Martin G, Lazarus A. Epidemiology and diagnosis of tuberculosis. Recognition of at­risk patients is key to prompt detection. Postgrad Med 2000
Aug;108(2):42­4, 47­50, 53­4.
Martin J, Dunn G, Hull R, Patel V, Minor PD. Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637­day
period of virus excretion. J Virol 2000; 74(7):3001­3010.
Martin J, Ferguson GL, Wood DJ, Minor PD. The vaccine origin of the 1968 epidemic of type 3 poliomyelitis in poland. Virology 2000 Dec 5;278(1):42­9
Martinetti M, De Silvestri A, Belloni C, Pasi A, Tinelli C, Pistorio A, Salvaneschi L, Rondini G, Avanzini MA, Cuccia M. Humoral response to recombinant
hepatitis B virus vaccine at birth: role of HLA and beyond. Clin Immunol 2000 Dec;97(3):234­40
Martinez, F., Sanchez, C., Gonzalez, L., Galmes, A., Pachon, I., Pelayo, T., and Pons, C. Two Outbreaks of Mumps in Children Vaccinated With the Rubini
Strain in Spain Indicate Low Vaccine Efficacy. Euro.Surveill 2000, 5 (7): 80­84.
Marwick C. Calling the shots: IOM report calls for immunization revisions. Institute of Medicine [news]. JAMA 2000 Aug 9;284(6):683­4.
Marwick C. Clearing the way for new combination vaccine use [news]. JAMA 2000;1280­1.
Marwick C. FDA calls bovine­based vaccines currently safe [news]. JAMA 2000 Sep 13;284(10):1231­2.
Marwick C. Merits, flaws of live virus flu vaccine debated [news]. JAMA 2000; 283(14):1814­1815.
Mason BW, Donnelly PD. Targeted mailing of information to improve uptake of measles, mumps, and rubella vaccine: a randomised controlled trial. Commun
Dis Public Health 2000; 3(1):67­68.
Mastrangelo, G., Rossi, C. R., Pfahlberg, A., Marzia, V., Barba, A., Baldo, M., Fadda, E., Milan, G., and Kolmel, K. F. Is there a relationship between
influenza vaccinations and risk of melanoma? A population­based case­control study Eur.J.Epidemiol. 2000, 16 (9): 777­782.
Mathe, G. Influenza and its vaccination in HIV1­AIDS patients [editorial] Biomed Pharmacother 2000 May;54(4):175­7
Matheson AJ, Goa KL. Diphtheria­tetanus­acellular pertussis vaccine adsorbed (Triacelluvax; DTaP3­CB): a review of its use in the prevention of Bordetella
pertussis infection. Paediatr Drugs 2000 Mar­2000 Apr 30;2(2):139­59.